{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:11:59Z","timestamp":1793052719344,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T00:00:00Z","timestamp":1456963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The immunogenicity of recombinant adenovirus serotype 5 (rAd5) vectors has been shown to be suppressed by neutralizing antibodies (NAbs) directed primarily against hexon hypervariable regions (HVRs). Preexisting immunity can be circumvented by replacing HVRs of rAd5 hexon with those derived from alternate adenovirus serotypes. However, chimeric modification of rAd5 hexon HVRs tends to cause low packaging efficiency or low proliferation of rAd5 vectors, but the related mechanism remains unclear. In this study, several Ad5-based vectors with precise replacement of HVRs with those derived from Ad37 and Ad43 were generated. We first observed that a HVR-exchanged rAd5 vector displayed a higher efficacy of the recombinant virus rescue and growth improvement compared with the rAd5 vector, although most hexon-chimeric rAd5 vectors constructed by us and other groups have proven to be nonviable or growth defective. We therefore evaluated the structural stability of the chimeric hexons and their interactions with the L4-100K chaperone. We showed that the viability of hexon-chimeric Ad5 vectors was not attributed to the structural stability of the chimeric hexon, but rather to the hexon maturation which was assisted by L4-100K. Our results suggested that the intricate interaction between hexon and L4-100K would determine the virus rescue and proliferation efficiency of hexon-chimeric rAd5 vectors.<\/jats:p>","DOI":"10.1038\/srep22464","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T10:18:41Z","timestamp":1457000321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Interaction between hexon and L4-100K determines virus rescue and growth of hexon-chimeric recombinant Ad5 vectors"],"prefix":"10.1038","volume":"6","author":[{"given":"Jingyi","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,3]]},"reference":[{"key":"BFsrep22464_CR1","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/jvi.70.7.4502-4508.1996","volume":"70","author":"S Huang","year":"1996","unstructured":"Huang, S., Kamata, T., Takada, Y., Ruggeri, Z. M. & Nemerow, G. R. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 70, 4502\u20134508 (1996).","journal-title":"J Virol"},{"key":"BFsrep22464_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-4781(02)00249-X","volume":"1575","author":"BG Barnett","year":"2002","unstructured":"Barnett, B. G., Crews, C. J. & Douglas, J. T. Targeted adenoviral vectors. Biochim Biophys Acta 1575, 1\u201314 (2002).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep22464_CR3","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.1128\/JVI.02385-06","volume":"81","author":"AJ Ullman","year":"2007","unstructured":"Ullman, A. J., Reich, N. C. & Hearing, P. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J Virol 81, 4744\u20134752, doi: 10.1128\/JVI.02385-06 (2007).","journal-title":"J Virol"},{"key":"BFsrep22464_CR4","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/mt.2009.152","volume":"17","author":"JA Greig","year":"2009","unstructured":"Greig, J. A. et al. Influence of coagulation factor x on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35 and chimeric Ad5\/Ad35 vectors. Mol Ther 17, 1683\u20131691, doi: 10.1038\/mt.2009.152 (2009).","journal-title":"Mol Ther"},{"key":"BFsrep22464_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nature04721","volume":"441","author":"DM Roberts","year":"2006","unstructured":"Roberts, D. M. et al. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 441, 239\u2013243, doi: 10.1038\/nature04721 (2006).","journal-title":"Nature"},{"key":"BFsrep22464_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1021\/mp100214b","volume":"8","author":"QL Matthews","year":"2011","unstructured":"Matthews, Q. L. Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach. Mol Pharm 8, 3\u201311, doi: 10.1021\/mp100214b (2011).","journal-title":"Mol Pharm"},{"key":"BFsrep22464_CR7","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1146\/annurev-biochem-060910-095130","volume":"81","author":"NG Abrescia","year":"2012","unstructured":"Abrescia, N. G., Bamford, D. H., Grimes, J. M. & Stuart, D. I. Structure unifies the viral universe. Annu Rev Biochem 81, 795\u2013822, doi: 10.1146\/annurev-biochem-060910-095130 (2012).","journal-title":"Annu Rev Biochem"},{"key":"BFsrep22464_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3390\/v4050847","volume":"4","author":"C San Martin","year":"2012","unstructured":"San Martin, C. Latest insights on adenovirus structure and assembly. Viruses 4, 847\u2013877, doi: 10.3390\/v4050847 (2012).","journal-title":"Viruses"},{"key":"BFsrep22464_CR9","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1128\/JVI.72.12.10260-10264.1998","volume":"72","author":"JG Gall","year":"1998","unstructured":"Gall, J. G., Crystal, R. G. & Falck-Pedersen, E. Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype. J Virol 72, 10260\u201310264 (1998).","journal-title":"J Virol"},{"key":"BFsrep22464_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1128\/JVI.02061-12","volume":"87","author":"OO Koyuncu","year":"2013","unstructured":"Koyuncu, O. O., Speiseder, T., Dobner, T. & Schmid, M. Amino acid exchanges in the putative nuclear export signal of adenovirus type 5 L4-100K severely reduce viral progeny due to effects on hexon biogenesis. J Virol 87, 1893\u20131898, doi: 10.1128\/JVI.02061-12 (2013).","journal-title":"J Virol"},{"key":"BFsrep22464_CR11","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1126\/science.3704642","volume":"232","author":"MM Roberts","year":"1986","unstructured":"Roberts, M. M., White, J. L., Grutter, M. G. & Burnett, R. M. Three-dimensional structure of the adenovirus major coat protein hexon. Science 232, 1148\u20131151 (1986).","journal-title":"Science"},{"key":"BFsrep22464_CR12","doi-asserted-by":"publisher","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","volume":"77","author":"JJ Rux","year":"2003","unstructured":"Rux, J. J., Kuser, P. R. & Burnett, R. M. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling and sequence-based methods. J Virol 77, 9553\u20139566 (2003).","journal-title":"J Virol"},{"key":"BFsrep22464_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1006\/mthe.1999.0001","volume":"1","author":"JJ Rux","year":"2000","unstructured":"Rux, J. J. & Burnett, R. M. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon. Mol Ther 1, 18\u201330, doi: 10.1006\/mthe.1999.0001 (2000).","journal-title":"Mol Ther"},{"key":"BFsrep22464_CR14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1006\/jmbi.1994.1593","volume":"242","author":"FK Athappilly","year":"1994","unstructured":"Athappilly, F. K., Murali, R., Rux, J. J., Cai, Z. & Burnett, R. M. The refined crystal structure of hexon, the major coat protein of adenovirus type 2, at 2.9 A resolution. J Mol Biol 242, 430\u2013455 (1994).","journal-title":"J Mol Biol"},{"key":"BFsrep22464_CR15","doi-asserted-by":"publisher","first-page":"11715","DOI":"10.1073\/pnas.1408462111","volume":"111","author":"VS Reddy","year":"2014","unstructured":"Reddy, V. S. & Nemerow, G. R. Structures and organization of adenovirus cement proteins provide insights into the role of capsid maturation in virus entry and infection. Proc Natl Acad Sci USA 111, 11715\u201311720, doi: 10.1073\/pnas.1408462111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep22464_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4155\/tde.12.155","volume":"4","author":"LK Medina-Kauwe","year":"2013","unstructured":"Medina-Kauwe, L. K. Development of adenovirus capsid proteins for targeted therapeutic delivery. Ther Deliv 4, 267\u2013277, doi: 10.4155\/tde.12.155 (2013).","journal-title":"Ther Deliv"},{"key":"BFsrep22464_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0042-6822(86)90367-3","volume":"152","author":"N Morin","year":"1986","unstructured":"Morin, N. & Boulanger, P. Hexon trimerization occurring in an assembly-defective, 100K temperature-sensitive mutant of adenovirus 2. Virology 152, 11\u201331 (1986).","journal-title":"Virology"},{"key":"BFsrep22464_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbrc.2012.03.125","volume":"421","author":"B Yu","year":"2012","unstructured":"Yu, B. et al. Chimeric hexon HVRs protein reflects partial function of adenovirus. Biochem Biophys Res Commun 421, 170\u2013176, doi: 10.1016\/j.bbrc.2012.03.125 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep22464_CR19","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1128\/JVI.06165-11","volume":"86","author":"RR Bradley","year":"2012","unstructured":"Bradley, R. R. et al. Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions. J Virol 86, 1267\u20131272, doi: 10.1128\/JVI.06165-11 (2012).","journal-title":"J Virol"},{"key":"BFsrep22464_CR20","doi-asserted-by":"publisher","first-page":"9661","DOI":"10.1128\/JVI.00462-13","volume":"87","author":"JT Bruder","year":"2013","unstructured":"Bruder, J. T. et al. Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors. J Virol 87, 9661\u20139671, doi: 10.1128\/JVI.00462-13 (2013).","journal-title":"J Virol"},{"key":"BFsrep22464_CR21","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1128\/JVI.00048-07","volume":"81","author":"I Madisch","year":"2007","unstructured":"Madisch, I. et al. Phylogenetic analysis and structural predictions of human adenovirus penton proteins as a basis for tissue-specific adenovirus vector design. J Virol 81, 8270\u20138281, doi: 10.1128\/JVI.00048-07 (2007).","journal-title":"J Virol"},{"key":"BFsrep22464_CR22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1126\/science.1187292","volume":"329","author":"VS Reddy","year":"2010","unstructured":"Reddy, V. S., Natchiar, S. K., Stewart, P. L. & Nemerow, G. R. Crystal structure of human adenovirus at 3.5 A resolution. Science 329, 1071\u20131075, doi: 10.1126\/science.1187292 (2010).","journal-title":"Science"},{"key":"BFsrep22464_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.coviro.2011.12.008","volume":"2","author":"GR Nemerow","year":"2012","unstructured":"Nemerow, G. R., Stewart, P. L. & Reddy, V. S. Structure of human adenovirus. Curr Opin Virol 2, 115\u2013121, doi: 10.1016\/j.coviro.2011.12.008 (2012).","journal-title":"Curr Opin Virol"},{"key":"BFsrep22464_CR24","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","volume":"172","author":"DH Barouch","year":"2004","unstructured":"Barouch, D. H. et al. Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity. J Immunol 172, 6290\u20136297 (2004).","journal-title":"J Immunol"},{"key":"BFsrep22464_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/sj.mt.6300024","volume":"15","author":"SE Hensley","year":"2007","unstructured":"Hensley, S. E. et al. Type I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector. Mol Ther 15, 393\u2013403, doi: 10.1038\/sj.mt.6300024 (2007).","journal-title":"Mol Ther"},{"key":"BFsrep22464_CR26","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.vaccine.2004.02.011","volume":"22","author":"OJ Ophorst","year":"2004","unstructured":"Ophorst, O. J. et al. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization and immunogenicity. Vaccine 22, 3035\u20133044, doi: 10.1016\/j.vaccine.2004.02.011 (2004).","journal-title":"Vaccine"},{"key":"BFsrep22464_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0092-8674(82)90134-9","volume":"31","author":"CL Cepko","year":"1982","unstructured":"Cepko, C. L. & Sharp, P. A. Assembly of adenovirus major capsid protein is mediated by a nonvirion protein. Cell 31, 407\u2013415 (1982).","journal-title":"Cell"},{"key":"BFsrep22464_CR28","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/jvi.33.3.1203-1207.1980","volume":"33","author":"EA Oosterom-Dragon","year":"1980","unstructured":"Oosterom-Dragon, E. A. & Ginsberg, H. S. Purification and preliminary immunological characterization of the type 5 adenovirus, nonstructural 100,000-dalton protein. J Virol 33, 1203\u20131207 (1980).","journal-title":"J Virol"},{"key":"BFsrep22464_CR29","first-page":"1","volume":"109","author":"L Philipson","year":"1984","unstructured":"Philipson, L. Structure and assembly of adenoviruses. Curr Top Microbiol Immunol 109, 1\u201352 (1984).","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFsrep22464_CR30","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jmb.2005.06.070","volume":"352","author":"SS Hong","year":"2005","unstructured":"Hong, S. S. et al. The 100K-chaperone protein from adenovirus serotype 2 (Subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses. J Mol Biol 352, 125\u2013138, doi: 10.1016\/j.jmb.2005.06.070 (2005).","journal-title":"J Mol Biol"},{"key":"BFsrep22464_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0042-6822(83)90285-4","volume":"124","author":"C Gambke","year":"1983","unstructured":"Gambke, C. & Deppert, W. Specific complex of the late nonstructural 100,000-dalton protein with newly synthesized hexon in adenovirus type 2-infected cells. Virology 124, 1\u201312 (1983).","journal-title":"Virology"},{"key":"BFsrep22464_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0042-6822(83)90402-6","volume":"129","author":"CL Cepko","year":"1983","unstructured":"Cepko, C. L. & Sharp, P. A. Analysis of Ad5 hexon and 100K ts mutants using conformation-specific monoclonal antibodies. Virology 129, 137\u2013154 (1983).","journal-title":"Virology"},{"key":"BFsrep22464_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1126\/science.1187433","volume":"329","author":"H Liu","year":"2010","unstructured":"Liu, H. et al. Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks. Science 329, 1038\u20131043, doi: 10.1126\/science.1187433 (2010).","journal-title":"Science"},{"key":"BFsrep22464_CR34","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1128\/JVI.02023-06","volume":"81","author":"SL Pichla-Gollon","year":"2007","unstructured":"Pichla-Gollon, S. L. et al. Structure-based identification of a major neutralizing site in an adenovirus hexon. J Virol 81, 1680\u20131689, doi: 10.1128\/JVI.02023-06 (2007).","journal-title":"J Virol"},{"key":"BFsrep22464_CR35","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.virusres.2011.06.017","volume":"160","author":"X Tian","year":"2011","unstructured":"Tian, X. et al. Construction and characterization of human adenovirus serotype 3 packaged by serotype 7 hexon. Virus Res 160, 214\u2013220, doi: 10.1016\/j.virusres.2011.06.017 (2011).","journal-title":"Virus Res"},{"key":"BFsrep22464_CR36","doi-asserted-by":"publisher","first-page":"12775","DOI":"10.1128\/JVI.76.24.12775-12782.2002","volume":"76","author":"H Wu","year":"2002","unstructured":"Wu, H. et al. Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon. J Virol 76, 12775\u201312782 (2002).","journal-title":"J Virol"},{"key":"BFsrep22464_CR37","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1128\/JCM.00156-11","volume":"49","author":"MP Walsh","year":"2011","unstructured":"Walsh, M. P. et al. Computational analysis of two species C human adenoviruses provides evidence of a novel virus. J Clin Microbiol 49, 3482\u20133490, doi: 10.1128\/JCM.00156-11 (2011).","journal-title":"J Clin Microbiol"},{"key":"BFsrep22464_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/0042-6822(84)90256-3","volume":"136","author":"N Morin","year":"1984","unstructured":"Morin, N. & Boulanger, P. Morphogenesis of human adenovirus type 2: sequence of entry of proteins into previral and viral particles. Virology 136, 153\u2013167 (1984).","journal-title":"Virology"},{"key":"BFsrep22464_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/10430340252769824","volume":"13","author":"R Youil","year":"2002","unstructured":"Youil, R. et al. Hexon gene switch strategy for the generation of chimeric recombinant adenovirus. Hum Gene Ther 13, 311\u2013320, doi: 10.1089\/10430340252769824 (2002).","journal-title":"Hum Gene Ther"},{"key":"BFsrep22464_CR40","doi-asserted-by":"publisher","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","volume":"29","author":"DH Barouch","year":"2011","unstructured":"Barouch, D. H. et al. International seroepidemiology of adenovirus serotypes 5, 26, 35 and 48 in pediatric and adult populations. Vaccine 29, 5203\u20135209, doi: 10.1016\/j.vaccine.2011.05.025 (2011).","journal-title":"Vaccine"},{"key":"BFsrep22464_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0042-6822(83)90358-6","volume":"124","author":"W Kruijer","year":"1983","unstructured":"Kruijer, W., Nicolas, J. C., van Schaik, F. M. & Sussenbach, J. S. Structure and function of DNA binding proteins from revertants of adenovirus type 5 mutants with a temperature-sensitive DNA replication. Virology 124, 425\u2013433 (1983).","journal-title":"Virology"},{"key":"BFsrep22464_CR42","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jmb.2005.11.048","volume":"356","author":"P Fuschiotti","year":"2006","unstructured":"Fuschiotti, P. et al. Structure of the dodecahedral penton particle from human adenovirus type 3. J Mol Biol 356, 510\u2013520, doi: 10.1016\/j.jmb.2005.11.048 (2006).","journal-title":"J Mol Biol"},{"key":"BFsrep22464_CR43","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.molcel.2004.11.041","volume":"17","author":"C Zubieta","year":"2005","unstructured":"Zubieta, C., Schoehn, G., Chroboczek, J. & Cusack, S. The structure of the human adenovirus 2 penton. Mol Cell 17, 121\u2013135, doi: 10.1016\/j.molcel.2004.11.041 (2005).","journal-title":"Mol Cell"},{"key":"BFsrep22464_CR44","doi-asserted-by":"publisher","first-page":"6973","DOI":"10.1128\/JVI.00123-06","volume":"80","author":"P Ostapchuk","year":"2006","unstructured":"Ostapchuk, P., Anderson, M. E., Chandrasekhar, S. & Hearing, P. The L4 22-kilodalton protein plays a role in packaging of the adenovirus genome. J Virol 80, 6973\u20136981, doi: 10.1128\/JVI.00123-06 (2006).","journal-title":"J Virol"},{"key":"BFsrep22464_CR45","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1016\/j.febslet.2007.06.024","volume":"581","author":"MA Samad","year":"2007","unstructured":"Samad, M. A., Okuwaki, M., Haruki, H. & Nagata, K. Physical and functional interaction between a nucleolar protein nucleophosmin\/B23 and adenovirus basic core proteins. FEBS Lett 581, 3283\u20133288, doi: 10.1016\/j.febslet.2007.06.024 (2007).","journal-title":"FEBS Lett"},{"key":"BFsrep22464_CR46","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1089\/10430349950016708","volume":"10","author":"P Ng","year":"1999","unstructured":"Ng, P. et al. A high-efficiency Cre\/loxP-based system for construction of adenoviral vectors. Hum Gene Ther 10, 2667\u20132672, doi: 10.1089\/10430349950016708 (1999).","journal-title":"Hum Gene Ther"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22464","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22464.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:33:44Z","timestamp":1672839224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,3]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,20]]}},"alternative-id":["BFsrep22464"],"URL":"https:\/\/doi.org\/10.1038\/srep22464","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,3]]},"assertion":[{"value":"27 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22464"}}